DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Reau N, Kwo P, Rhee S. , et al.
MAGELLAN-2: safety and efficacy of glecaprevir/pibrentasvir in liver or renal transplant adults with chronic hepatitis C genotype 1–6 infection.
J Hepatol 2017;
66 (01) S90-S1
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.